Protalix Company

Protalix is a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system. Its pipeline consists of proprietary, potentially clinically superior versions of recombinant therapeutic proteins that target established pharmaceutical markets.
Technology: Biotechnology, Pharmaceutical, Therapeutics
Industry: Personalized Medicine
Headquarters: Carmiel, Israel
Founded Date: 1993
Employees Number: 200-500
Funding Status: IPO

Visit Website
Register and Claim Ownership